The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sulphonamides-Global Market Insights and Sales Trends 2025
Synopsis
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
The global Sulphonamides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sulphonamides in various end use industries. The expanding demands from the Skin Infections, Gastro Intestinal Tract (GIT) Infection and Meningitis,, are propelling Sulphonamides market. Orally Absorbable Sulfonamide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sulphonamides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sulphonamides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sulphonamides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sulphonamides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sulphonamides covered in this report include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, GlaxoSmithKline, King Pharmaceuticals, Mylan Pharmaceuticals, Novartis International AG, Pfizer and Par Pharmaceutical, etc.
The global Sulphonamides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Global Sulphonamides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sulphonamides market, Segment by Type:
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Global Sulphonamides market, by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sulphonamides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sulphonamides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sulfonamides (sulphonamides) are a group of man-made (synthetic) medicines that contain the sulfonamide chemical group. They may also be called sulfa drugs. Many people use the term sulfonamide imprecisely to refer only to antibiotics that have a sulfonamide functional group in their chemical structure.
The global Sulphonamides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sulphonamides in various end use industries. The expanding demands from the Skin Infections, Gastro Intestinal Tract (GIT) Infection and Meningitis,, are propelling Sulphonamides market. Orally Absorbable Sulfonamide, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sulphonamides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sulphonamides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sulphonamides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sulphonamides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sulphonamides covered in this report include Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals, Bayer AG, GlaxoSmithKline, King Pharmaceuticals, Mylan Pharmaceuticals, Novartis International AG, Pfizer and Par Pharmaceutical, etc.
The global Sulphonamides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories
Global Sulphonamides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sulphonamides market, Segment by Type:
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Global Sulphonamides market, by Application
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sulphonamides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sulphonamides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sulphonamides Market Overview
1.1 Sulphonamides Product Overview
1.2 Sulphonamides Market Segment by Type
1.2.1 Orally Absorbable Sulfonamide
1.2.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
1.2.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
1.3 Global Sulphonamides Market Size by Type
1.3.1 Global Sulphonamides Market Size Overview by Type (2018-2029)
1.3.2 Global Sulphonamides Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sulphonamides Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sulphonamides Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sulphonamides Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sulphonamides Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sulphonamides Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sulphonamides Sales Breakdown by Type (2018-2023)
2 Global Sulphonamides Market Competition by Company
2.1 Global Top Players by Sulphonamides Sales (2018-2023)
2.2 Global Top Players by Sulphonamides Revenue (2018-2023)
2.3 Global Top Players by Sulphonamides Price (2018-2023)
2.4 Global Top Manufacturers Sulphonamides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sulphonamides Market Competitive Situation and Trends
2.5.1 Sulphonamides Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sulphonamides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sulphonamides as of 2022)
2.7 Date of Key Manufacturers Enter into Sulphonamides Market
2.8 Key Manufacturers Sulphonamides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sulphonamides Status and Outlook by Region
3.1 Global Sulphonamides Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sulphonamides Historic Market Size by Region
3.2.1 Global Sulphonamides Sales in Volume by Region (2018-2023)
3.2.2 Global Sulphonamides Sales in Value by Region (2018-2023)
3.2.3 Global Sulphonamides Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sulphonamides Forecasted Market Size by Region
3.3.1 Global Sulphonamides Sales in Volume by Region (2024-2029)
3.3.2 Global Sulphonamides Sales in Value by Region (2024-2029)
3.3.3 Global Sulphonamides Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sulphonamides by Application
4.1 Sulphonamides Market Segment by Application
4.1.1 Skin Infections
4.1.2 Gastro Intestinal Tract (GIT) Infection
4.1.3 Meningitis
4.2 Global Sulphonamides Market Size by Application
4.2.1 Global Sulphonamides Market Size Overview by Application (2018-2029)
4.2.2 Global Sulphonamides Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sulphonamides Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sulphonamides Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sulphonamides Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sulphonamides Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sulphonamides Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sulphonamides Sales Breakdown by Application (2018-2023)
5 North America Sulphonamides by Country
5.1 North America Sulphonamides Historic Market Size by Country
5.1.1 North America Sulphonamides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sulphonamides Sales in Volume by Country (2018-2023)
5.1.3 North America Sulphonamides Sales in Value by Country (2018-2023)
5.2 North America Sulphonamides Forecasted Market Size by Country
5.2.1 North America Sulphonamides Sales in Volume by Country (2024-2029)
5.2.2 North America Sulphonamides Sales in Value by Country (2024-2029)
6 Europe Sulphonamides by Country
6.1 Europe Sulphonamides Historic Market Size by Country
6.1.1 Europe Sulphonamides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sulphonamides Sales in Volume by Country (2018-2023)
6.1.3 Europe Sulphonamides Sales in Value by Country (2018-2023)
6.2 Europe Sulphonamides Forecasted Market Size by Country
6.2.1 Europe Sulphonamides Sales in Volume by Country (2024-2029)
6.2.2 Europe Sulphonamides Sales in Value by Country (2024-2029)
7 Asia-Pacific Sulphonamides by Region
7.1 Asia-Pacific Sulphonamides Historic Market Size by Region
7.1.1 Asia-Pacific Sulphonamides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sulphonamides Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sulphonamides Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sulphonamides Forecasted Market Size by Region
7.2.1 Asia-Pacific Sulphonamides Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sulphonamides Sales in Value by Region (2024-2029)
8 Latin America Sulphonamides by Country
8.1 Latin America Sulphonamides Historic Market Size by Country
8.1.1 Latin America Sulphonamides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sulphonamides Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sulphonamides Sales in Value by Country (2018-2023)
8.2 Latin America Sulphonamides Forecasted Market Size by Country
8.2.1 Latin America Sulphonamides Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sulphonamides Sales in Value by Country (2024-2029)
9 Middle East and Africa Sulphonamides by Country
9.1 Middle East and Africa Sulphonamides Historic Market Size by Country
9.1.1 Middle East and Africa Sulphonamides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sulphonamides Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sulphonamides Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sulphonamides Forecasted Market Size by Country
9.2.1 Middle East and Africa Sulphonamides Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sulphonamides Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Sulphonamides Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Boehringer Ingelheim Pharmaceuticals
10.2.1 Boehringer Ingelheim Pharmaceuticals Company Information
10.2.2 Boehringer Ingelheim Pharmaceuticals Introduction and Business Overview
10.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Products Offered
10.2.5 Boehringer Ingelheim Pharmaceuticals Recent Development
10.3 Bayer AG
10.3.1 Bayer AG Company Information
10.3.2 Bayer AG Introduction and Business Overview
10.3.3 Bayer AG Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bayer AG Sulphonamides Products Offered
10.3.5 Bayer AG Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GlaxoSmithKline Sulphonamides Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 King Pharmaceuticals
10.5.1 King Pharmaceuticals Company Information
10.5.2 King Pharmaceuticals Introduction and Business Overview
10.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.5.4 King Pharmaceuticals Sulphonamides Products Offered
10.5.5 King Pharmaceuticals Recent Development
10.6 Mylan Pharmaceuticals
10.6.1 Mylan Pharmaceuticals Company Information
10.6.2 Mylan Pharmaceuticals Introduction and Business Overview
10.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mylan Pharmaceuticals Sulphonamides Products Offered
10.6.5 Mylan Pharmaceuticals Recent Development
10.7 Novartis International AG
10.7.1 Novartis International AG Company Information
10.7.2 Novartis International AG Introduction and Business Overview
10.7.3 Novartis International AG Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novartis International AG Sulphonamides Products Offered
10.7.5 Novartis International AG Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Sulphonamides Products Offered
10.8.5 Pfizer Recent Development
10.9 Par Pharmaceutical
10.9.1 Par Pharmaceutical Company Information
10.9.2 Par Pharmaceutical Introduction and Business Overview
10.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Par Pharmaceutical Sulphonamides Products Offered
10.9.5 Par Pharmaceutical Recent Development
10.10 Roche Holding AG
10.10.1 Roche Holding AG Company Information
10.10.2 Roche Holding AG Introduction and Business Overview
10.10.3 Roche Holding AG Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Roche Holding AG Sulphonamides Products Offered
10.10.5 Roche Holding AG Recent Development
10.11 Sanofi Aventis
10.11.1 Sanofi Aventis Company Information
10.11.2 Sanofi Aventis Introduction and Business Overview
10.11.3 Sanofi Aventis Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sanofi Aventis Sulphonamides Products Offered
10.11.5 Sanofi Aventis Recent Development
10.12 Stiefel Laboratories
10.12.1 Stiefel Laboratories Company Information
10.12.2 Stiefel Laboratories Introduction and Business Overview
10.12.3 Stiefel Laboratories Sulphonamides Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Stiefel Laboratories Sulphonamides Products Offered
10.12.5 Stiefel Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sulphonamides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sulphonamides Industrial Chain Analysis
11.4 Sulphonamides Market Dynamics
11.4.1 Sulphonamides Industry Trends
11.4.2 Sulphonamides Market Drivers
11.4.3 Sulphonamides Market Challenges
11.4.4 Sulphonamides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sulphonamides Distributors
12.3 Sulphonamides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
